A nurse administers a dose of the Moderna COVID-19 vaccine to an elderly woman at a North Memorial Health vaccination clinic in Brooklyn Center on March 9, 2021. (Aaron Lavinsky/The Minnesota Star Tri ...

Chinese biotech start-ups are going up against Western drug makers - and they could win A decade ago, treating cancer with personalised mRNA vaccines seemed like a US$1 million gamble per patient, a ...

Immatics' lead asset, IMA203, shows promising early data with a 57% ORR in heavily pretreated patients, but toxicity concerns ...